Vir Biotechnology Inc.

NASDAQ: VIR · Real-Time Price · USD
5.28
0.05 (0.96%)
At close: Jun 04, 2025, 3:59 PM
5.33
1.13%
After-hours: Jun 04, 2025, 06:33 PM EDT

Vir Biotechnology Statistics

Share Statistics

Vir Biotechnology has 138.24M shares outstanding. The number of shares has increased by 0.8% in one year.

Shares Outstanding 138.24M
Shares Change (YoY) 0.8%
Shares Change (QoQ) -0.42%
Owned by Institutions (%) 64.98%
Shares Floating n/a
Failed to Deliver (FTD) Shares 17
FTD / Avg. Volume n/a

Short Selling Information

The latest short interest is 10.94M, so 7.92% of the outstanding shares have been sold short.

Short Interest 10.94M
Short % of Shares Out 7.92%
Short % of Float 12.79%
Short Ratio (days to cover) 6.77

Valuation Ratios

The PE ratio is -1.92 and the forward PE ratio is -1.64. Vir Biotechnology's PEG ratio is 0.12.

PE Ratio -1.92
Forward PE -1.64
PS Ratio 13.48
Forward PS 3.9
PB Ratio 0.87
P/FCF Ratio -2.2
PEG Ratio 0.12
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Vir Biotechnology.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.71, with a Debt / Equity ratio of 0.09.

Current Ratio 8.71
Quick Ratio 8.71
Debt / Equity 0.09
Debt / EBITDA -0.18
Debt / FCF -0.22
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $181,875
Profits Per Employee $-1,279,313.73
Employee Count 408
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

Income Tax -1.15M
Effective Tax Rate 0.22%

Stock Price Statistics

The stock price has increased by -50.47% in the last 52 weeks. The beta is 1.36, so Vir Biotechnology's price volatility has been higher than the market average.

Beta 1.36
52-Week Price Change -50.47%
50-Day Moving Average 5.58
200-Day Moving Average 7.67
Relative Strength Index (RSI) 51.07
Average Volume (20 Days) 1,369,350

Income Statement

In the last 12 months, Vir Biotechnology had revenue of 74.2M and earned -521.96M in profits. Earnings per share was -3.83.

Revenue 74.2M
Gross Profit 73.36M
Operating Income -587.16M
Net Income -521.96M
EBITDA -537.61M
EBIT -552.17M
Earnings Per Share (EPS) -3.83
Full Income Statement

Balance Sheet

The company has 312.33M in cash and 97.89M in debt, giving a net cash position of 214.44M.

Cash & Cash Equivalents 312.33M
Total Debt 97.89M
Net Cash 214.44M
Retained Earnings -759.78M
Total Assets 1.31B
Working Capital 794.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -446.35M and capital expenditures -7.3M, giving a free cash flow of -453.65M.

Operating Cash Flow -446.35M
Capital Expenditures -7.3M
Free Cash Flow -453.65M
FCF Per Share -3.33
Full Cash Flow Statement

Margins

Gross margin is 98.86%, with operating and profit margins of -791.27% and -703.4%.

Gross Margin 98.86%
Operating Margin -791.27%
Pretax Margin -704.95%
Profit Margin -703.4%
EBITDA Margin -724.49%
EBIT Margin -791.27%
FCF Margin -611.35%

Dividends & Yields

VIR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for VIR is $20, which is 281.7% higher than the current price. The consensus rating is "Buy".

Price Target $20
Price Target Difference 281.7%
Analyst Consensus Buy
Analyst Count 7
Stock Forecasts

Scores

Altman Z-Score -0.1
Piotroski F-Score 2